Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Melanoma 34Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Ovarian Neoplasms 3Neoplasms 3Brain Neoplasms 3Skin Neoplasms 2Neoplasms by Site 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Thoracic Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Pancreatic Neoplasms 1Noonan Syndrome 1Neoplasms, Squamous Cell 1Neoplasms by Histologic Type 1Multiple Myeloma 1Lung Neoplasms 1Lung Diseases 1Laryngeal Neoplasms 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1Gastrointestinal Neoplasms 1Erdheim-Chester Disease 1

Interventions

pembrolizumab 4Drug Therapy 3Temozolomide 2Radiation 2Paclitaxel 2Nivolumab 2Cisplatin 2Bevacizumab 2vocimagene amiretrorepvec 1ulixertinib 1temsirolimus 1selinexor 1rovalpituzumab tesirine 1regorafenib 1pazopanib 1niraparib 1imetelstat 1fludarabine 1erythromycin propionate-N-acetylcysteinate 1epacadostat 1efineptakin alfa 1durvalumab 1dostarlimab 1cobimetinib 1cediranib 1cc-486 1carboxyamido-triazole 1bemcentinib 1aflibercept 1WP1066 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × cobimetinib × Dermatologic × Clear all
NCT04190628 2024-05-21

Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors

ABM Therapeutics Corporation

Phase 1 Terminated
53 enrolled
CNSDermatologicGastrointestinalGynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Glioblastoma, Melanoma, Ovarian Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡